The Use of Registries to Improve Cancer Treatment: A National Database for Patients Treated with Interleukin-2 (IL-2)

Registries evaluating un-randomized patients have provided valuable information with respect to a therapy’s utility, treatment practices, and evolution over time. While immunotherapy for cancer has been around for more than three decades, data collection in the form of a registry has not been undert...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufman, Howard L., Wong, Michael K., Daniels, Gregory A., McDermott, David F., Aung, Sandra, Lowder, James N., Morse, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251407/
https://www.ncbi.nlm.nih.gov/pubmed/25562142
http://dx.doi.org/10.3390/jpm4010052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251407/
https://www.ncbi.nlm.nih.gov/pubmed/25562142
http://dx.doi.org/10.3390/jpm4010052

Ejemplares similares